http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5219330-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eacde19a67c7dd1e7aa6092cc11d96a5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S128-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172
filingDate 1991-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68e74cb61d734f2edd05366941a480c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfeb1e79c77e60da2e85baf148e79709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1b948aae430c8c6ca4f9e745cdc39de
publicationDate 1993-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5219330-A
titleOfInvention Method and apparatus for preprogrammed infusion of iv medicaments
abstract An apparatus for infusing TPN fluids to a patient includes a source of fluid, a pump for infusing fluid from the source to the patient, and a computer for controlling the operation of the pump. During the operation of the apparatus the infusion rate of the pump is varied according to an infusion regimen that is based on the volume of fluid to be infused and the time during which the fluid is to be infused. This regimen is characterized by a trifurcated ramp up region having interrelated incremental rates of infusion which transition the pump from a zero rate of infusion to a steady state rate of infusion. The infusion regimen is also characterized by a period of steady state infusion which follows the ramp up region, and a ramp down region in which the infusion rate is decremented from the steady state rate based on the remaining volume of fluid to be infused to the patient and the remaining time for infusing this remaining volume of fluid. Infusion rate changes in both the ramp up and ramp down regions is accomplished in steps. Depending on the calculated steady state infusion rate, the step sizes may be either 5 ml/hr or 1 ml/hr. The different time intervals between steps in the ramp up region are related to each other and to the total time for infusing fluids to the patient and the time intervals between steps in the ramp down region are controlled by the computer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10552577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106823049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10971257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8747390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016554-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8083503-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9463273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9669160-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8496613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10943687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11367533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013216679-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008172044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8137083-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006184123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638781-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10224117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7018361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008513142-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8382447-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8888738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11676694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7608060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8105269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8062008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291763-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10089443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10569016-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10095840-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11575673-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10061899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607492-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8882701-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101606157-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11107574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10068061-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8696632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9937289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11495334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11516183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011137239-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10052049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8961461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10818387-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7934912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006064053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8775196-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7927313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8567235-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6997905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5772635-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016559-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002147237-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11257580-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9008803-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006047270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11576594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012277732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10272190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9833177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003233069-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11302433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9474856-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014364839-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10173008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5695464-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10556062-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10347374-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9514518-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10518030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8234128-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10092690-B2
priorityDate 1991-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4785799-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749

Total number of triples: 100.